← Database
Antimicrobial / Host-Defense Peptide

LL-37

Third-party suppliers · research use only · not an endorsement. Some links are affiliate links — purchases made through them may earn this site a commission.
Overview

A naturally occurring host-defense peptide with antimicrobial and immunomodulatory roles, studied extensively in cells and disease associations; not a marketed therapeutic.

How it works

LL-37 is the human body's main cathelicidin — a natural 'host-defense' peptide that forms part of our innate immune front line.

It's a positively charged, membrane-active peptide: it can punch holes in the membranes of bacteria and other microbes, and it also signals to the immune system, guiding immune-cell movement, wound healing, and inflammation. Notably, its inflammatory role is context-dependent and can sometimes be pro-inflammatory.

It's been studied extensively in the lab and in disease associations, but those dual, context-dependent roles make it hard to turn into a clean therapeutic, and it is not a marketed drug.

Mechanism · Detailed Analysis
Molecular targetA cationic, amphipathic host-defence peptide (the human cathelicidin) that interacts with microbial membranes and host receptors.
Signaling & downstream effectsDisrupts microbial membranes and also modulates chemotaxis, wound healing, and inflammatory signalling — sometimes pro-inflammatory depending on context.
Evidence & caveatsHeavily studied in vitro; its context-dependent, dual roles make therapeutic translation complex.
Published EvidenceLoading cited studies from PubMed…
Human Data ···

Searching the published record…

Animal ···

Searching the published record…

In Vitro ···

Searching the published record…

Educational aggregation of public literature. Not medical advice and not a recommendation to use any compound. Many compounds here are not approved for human use. Consult a licensed clinician.